1st Quarter - Report

DUTKO WORLDWIDE, LLC for GENENTECH INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 9, 2009 $60,000 Replaced
1st Quarter - Amendment Apr 13, 2009 $60,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
JUDITH LEMONS —
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), S. 515 (111th), S. 610 (111th), H.R. 1260 (111th)

Copyright/Patent/Trademark CPT

Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 610 (111th), H.R. 1260 (111th), H.R. 1548 (111th), S. 515 (111th)

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS New 2008).
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 610 (111th), S. 515 (111th), H.R. 1260 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.